Healthstream (HSTM) EBITDA (2010 - 2026)

Healthstream (HSTM) has 17 years of EBITDA data on file, last reported at $7.5 million in Q1 2026.

• EBITDA for Q1 2026 came in at $7.5 million, up 71.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.4 million (up 502.92% YoY), and the FY2025 annual result was $24.1 million, up 168.57% from the prior year.
• EBITDA rose to $7.5 million in Q1 2026 per HSTM's latest filing, from $2.4 million in the prior quarter.
• Over five years, EBITDA peaked at $7.6 million in Q3 2025 and troughed at -$11.4 million in Q4 2024.
• A 5-year average of $2.9 million and a median of $4.0 million in 2022 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA soared 144.7% in 2022, then sank 356.03% in 2023.
• A 5-year view of EBITDA shows it stood at $3.1 million in 2022, then slumped by 356.03% to -$7.9 million in 2023, then slumped by 44.85% to -$11.4 million in 2024, then surged by 121.07% to $2.4 million in 2025, then soared by 212.48% to $7.5 million in 2026.
• Business Quant data shows HSTM's EBITDA at $7.5 million in Q1 2026, $2.4 million in Q4 2025, and $7.6 million in Q3 2025.